University of Calgary
UofC Navigation

Home

Researchers in Profile

BPA and its substitute alter brain growth, linked to hyperactivity

Deborah Kurrasch, PhD, is the lead researcher in a study published in the Proceedings of the National Academy of Sciences (PNAS) which has provided evidence that BPA and BPS impair the growth of neurons in zebrafish. The findings are so worrying the lead researcher and her colleagues are calling for “removal of all bisphenols from consumer merchandise".  

Read more   

Video

Newsweek

World experts in child brain health convene in Calgary

For the first time in Calgary, an internationally distinguished panel of experts in child neurology and developmental neurosciences will convene at the Alberta Children’s Hospital to share information about advances in pediatric brain health. They will be attending the Inaugural Robert Haslam Conference April 1-2 at the hospital’s amphitheatre.                Photo Gallery

International leaders in modelling genetic diseases: ACHRI Symposium

The fly, fish, mouse and worm – they’re the model organisms used to investigate the basic processes shared by all living creatures. This year's research symposium at the Alberta Children’s Hospital Research Institute April 15 will examine how to optimize the study of genetic diseases in these models from mechanism to therapy. Four international speakers will be addressing the symposium, joined by four experts from the University of Calgary. ACHRI registration

Improving diagnosis and treatments of rare diseases

Rare Disease Day gives communities an opportunity to raise awareness about research and support the many families affected by these diseases. To find a diagnosis for his condition, Enzo was enrolled in a Canadian research study using rapid DNA sequencing and analysis at the Alberta Children’s Hospital Research Institute (ACHRI).

AIHS - PRIHS Child Health Grant

Karen Benzies, PhD, Faculty of Nursing and Dr. Abhay Lodha, Department of Paediatrics, are the leads in a family integrated care study in neo-natal intensive care units in Alberta, funded by Alberta Innovates-Health Solutions (PRIHS) and awarded $750,000 for this three-year study.